These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 6156344)

  • 1. Antihypertensive activity of (-) moprolol in man: double-blind comparison of enantiomers.
    Ghirardi P; Grosso F
    J Cardiovasc Pharmacol; 1980; 2(4):471-2. PubMed ID: 6156344
    [No Abstract]   [Full Text] [Related]  

  • 2. [The cardiovascular effects of the optical isomers of 1-(0-methoxy-phenoxy-)-3-isopropylamino-2-propanolo-hydrochloride (moprolol)].
    Merlo L; Brusoni B; Mussini E; Ghirardi P
    Boll Soc Ital Cardiol; 1980; 25(8):955-61. PubMed ID: 6116496
    [No Abstract]   [Full Text] [Related]  

  • 3. The pharmacokinetics of dl- and l-moprolol in the human.
    Harvengt C; Desager JP
    Int J Clin Pharmacol Ther Toxicol; 1982 Feb; 20(2):57-61. PubMed ID: 6120901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Electrophysiological evaluation of the beta-blocking properties and direct membrane effects of l-moprolol and its enantiomer d-moprolol.
    Porciatti F; Cerbai E; Masini I; Mugelli A
    Arch Int Pharmacodyn Ther; 1989; 299():200-9. PubMed ID: 2570555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification and determination of the enantiomers of moprolol and their metabolites in human urine by high-performance liquid chromatography and gas chromatography-mass spectrometry.
    Li F; Bi H; Côté M; Cooper S
    J Chromatogr; 1993 Dec; 622(2):187-95. PubMed ID: 7908669
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and pharmacological study of a thiophene analogue of moprolol and related compounds.
    el-Ashmawy MB; Lissavetzky J; Darias V; Martín-Herrera D
    Arch Pharm (Weinheim); 1991 Jan; 324(1):45-8. PubMed ID: 1675047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tolerability of high doses of (-)-moprolol in healthy volunteers.
    Triulzi MO; Balice G; Gentile F; Rossini GL; Fattori CM
    Eur J Clin Pharmacol; 1982; 22(4):377-8. PubMed ID: 6125397
    [No Abstract]   [Full Text] [Related]  

  • 8. Influence of salt intake on the antihypertensive effect of carvedilol.
    Ruilope LM; Lahera V
    J Hypertens Suppl; 1993 Jun; 11(4):S17-9. PubMed ID: 8104238
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antihypertensive indole derivatives of phenoxypropanolamines with beta-adrenergic receptor antagonist and vasodilating activity.
    Kreighbaum WE; Matier WL; Dennis RD; Minielli JL; Deitchman D; Perhach JL; Comer WT
    J Med Chem; 1980 Mar; 23(3):285-9. PubMed ID: 6102605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies on agents with vasodilator and beta-blocking activities. II.
    Seki T; Takezaki T; Ohuchi R; Ohuyabu H; Tanimoto Y; Yamaguchi T; Saitoh M; Ishimori T; Yasuda K
    Chem Pharm Bull (Tokyo); 1995 Feb; 43(2):247-55. PubMed ID: 7728931
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antihypertensive effect of trimepranol, a new beta-blocking agent.
    Jounela AJ; Pentikäinen PJ; Neuvonen PJ
    Int J Clin Pharmacol Biopharm; 1978 Apr; 16(4):183-8. PubMed ID: 25847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of indenolol on blood pressure, lower limb blood flow, adrenergic reflexes, and plasma renin activity.
    Poggesi L; Masotti G; Boddi M; Neri Serneri GG
    Clin Pharmacol Ther; 1987 Mar; 41(3):344-50. PubMed ID: 2880689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 2-(Isoxazolylethenyl)phenoxypropanolamines: a new class of beta-receptor antagonists with antihypertensive activity.
    Franke A; Frickel FF; Gries J; Lenke D; Schlecker R; Thieme PD
    J Med Chem; 1981 Dec; 24(12):1460-4. PubMed ID: 6118439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The hemodynamic effects on the portal system of levomoprolol and propranolol in rats with an enhanced adrenergic tonus].
    Santambrogio R; Opocher E; Galeotti F; Montorsi M; Cucchiaro G; Gagliano G; Spina GP
    Minerva Med; 1989 Aug; 80(8):949-51. PubMed ID: 2571957
    [No Abstract]   [Full Text] [Related]  

  • 15. [Comparison of clinical usefulness of beta-blocker in aged and younger essential hypertension. Double blind trial using bunitrolol].
    Kuramoto K; Ikeda M; Arakawa K; Inagaki Y; Kaneko Y; Masuyama Y; Yamazaki N; Tsuchiya M
    Nihon Ronen Igakkai Zasshi; 1984 Jan; 21(1):20-6. PubMed ID: 6145808
    [No Abstract]   [Full Text] [Related]  

  • 16. Does beta 1-selective agonistic activity interfere with the antihypertensive efficacy of beta 1-selective blocking agents?
    Leonetti G; Sampieri L; Cuspidi C; Terzoli L; Rupoli L; Fruscio M; Gradnik R; Zanchetti A
    J Hypertens Suppl; 1985 Dec; 3(3):S243-5. PubMed ID: 2908819
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An assessment of the partial agonist activity of Ro 31-1118, flusoxolol and pindolol in man.
    McCaffrey PM; Riddell JG; Shanks RG
    Br J Clin Pharmacol; 1987 Nov; 24(5):571-80. PubMed ID: 2893634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel antihypertensive drug reveals unexpected complexities in beta-adrenoceptor pharmacology.
    Boudier HS; Abbott A
    Trends Pharmacol Sci; 1989 Dec; 10(12):469-71. PubMed ID: 2575812
    [No Abstract]   [Full Text] [Related]  

  • 19. Hemodynamic effects of carvedilol after acute oral administration in hypertensive and normal subjects.
    Cournot A; Lim C; Duchier J; Safar M
    J Cardiovasc Pharmacol; 1992; 19 Suppl 1():S35-9. PubMed ID: 1378147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemoenzymatic Route for the Synthesis of (S)-Moprolol, a Potential β-Blocker.
    Ghosh S; Bhaumik J; Banoth L; Banesh S; Banerjee UC
    Chirality; 2016 Apr; 28(4):313-8. PubMed ID: 26821612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.